St. Jude Gets Japanese Approval for Heart Failure Treatment Products

 

July 17, 2007

July 17, 2007 - St. Jude Medical Inc. today announced that it received regulatory approval from the Japanese Ministry of Health, Labor and Welfare and reimbursement approval for its first CRT-D systems to be marketed in Japan.

The two new systems used to treat heart failure patients have been approved, including the Atlas HF CRT-D (cardiac resynchronization therapy defibrillator) and the Epic HF CRT-D, which are used in conjunction with the QuickSite left-heart lead and delivered through the Apeel CS catheter delivery system.

The Atlas HF CRT-D reportedly delivers high output and tailored waveforms for patients with hearts that are difficult to defibrillate. The Epic HF CRT-D is designed for improved patient comfort.

For more information: www.sjm.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.